Press Releases Year None2025202420232022202120202019 Aug 08, 2025 Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results Jul 15, 2025 Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib May 13, 2025 Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2025 Financial Results May 01, 2025 Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics Apr 25, 2025 Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025 Mar 31, 2025 Repare Therapeutics Announces Leadership Transitions Mar 07, 2025 Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Mar 03, 2025 Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results Jan 09, 2025 Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions